Masashi Takayanagi
Papers
1
Total Citations
9
H-Index
1
About
Dr. Masashi Takayanagi is a leading colorectal surgeon whose research focuses on advancing minimally invasive techniques for rectal cancer treatment. His work centers on comparing robotic and laparoscopic surgical approaches, with particular emphasis on oncological outcomes such as circumferential resection margin (CRM) positivity. In his highly cited 2024 systematic review and meta-analysis, Dr. Takayanagi demonstrated that robotic surgery significantly reduces the risk of CRM positivity compared to conventional laparoscopic surgery in patients undergoing mesorectal excision for rectal cancer. This finding has critical implications for surgical decision-making, as CRM status is a key predictor of local recurrence and survival. His meta-analysis, which has already garnered 9 citations, synthesizes evidence from multiple studies to provide robust, practice-changing conclusions. Dr. Takayanagi’s contributions are helping to define the role of robotic technology in colorectal surgery, offering patients potentially better oncological outcomes through precision and enhanced visualization. His work continues to influence surgical protocols and training, solidifying his reputation as a key voice in the evolution of rectal cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1